Human mopnoclonal antibodies are in demand for cancer therapeutics. Human Mab can be produced in transgenic mice called: xenomice produced by Abgenix and Medarex. Synthetic human antibodies are produced by Morphosys in Germany-subdivision: Antibodies by Design- using a technique called HuCAL(Human Combinatorial Antibody Library).

What are the Ab candidates for clinical trials or already in use derived from the above technologies?

There is a Phase III clinical trial study of HuMax-CD4 (Zanolimumab) human monoclonal antibody to treat Mycosis Fungoides (T-Cell Lymphoma)

http://www.clinicaltrials.gov/show/NCT00127881

Another has been completed for to study the Human Anti-TNF monoclonal antibody, Adalimumab (Abbot Labs), for the induction of clinical remission in subjects with Crohn's Disease

http://www.clinicaltrials.gov/ct/show/NCT00105300